Table 3. Meta-analysis results of HLA-DP/DQ and STAT4 polymorphisms with HCC development.
SNPs | Gene | case/control | OR | 95%CI | I2 | Effects model | |
rs3077 | HLA-DP | 2997/3738 | 0.94 | 0.87–1.02 | 46.7% | F | |
rs3077 | HLA-DP | 2997/3738 | 0.95 | 0.84–1.06 | 46.7% | R | |
rs9277535 | HLA-DP | 3386/5621 | 1.04 | 0.97–1.11 | 5.7% | F | |
rs7453920 | HLA-DQ | 2813/3347 | 0.89 | 0.76–1.02 | 28.0% | F | |
rs7574865 | STAT4 | 962/1418 | 0.87 | 0.74–1.03 | 0.0% | F |
Note: OR, odds ratio; F, fixed-effects model; R, random-effects model.